Search

Filter:

Search Results

Leading U.S. hospital group target of external cyberattack

and that it would offer identify-theft protection services to those individuals who were affected by the data ...

Stubborn Valeant powers ahead with extended Allergan buyout offer

Valeant's ($VRX) tender offer for Allergan ($AGN) isn't expiring just yet. The company has extended the deadline to Dec. 31, giving it and activist investor partner Bill Ackman a few more months to go after deal-averse Allergan. At least one supporter is betting heavily that the Canadian ...

Cubist could be a Big Pharma target; Biotech IT outfit Comprehend raises $21M;

offer? Item > FDA targets off-label use of intranasal splint, with safety alert and Class I recall ...

After Walgreens avoids inversion, will Medtronic modify its Covidien offer?

closed yesterday at $87.26 while Medtronic's offer values each at $96.12, representing a disparity ...

Chugai skyrockets on Roche buyout rumors; Apotex recalls transplant drug;

Covidien offer? Item Biotech News @FierceBiotech: After a few days in Copenhagen, looks like Novo's ...

Biogen ready to steal market share with newly minted MS drug Plegridy

lesions by at least 67%. Biogen CEO George A. Scangos "Plegridy offers people with MS robust ...

Study: Heart rhythm telemetry implants improve patient outcomes

to offer both single- and dual-chamber pacemakers approved for use in an MRI environment. Biotronik ...

Shire bails out a contractor to keep its drug on the market

FiercePharmaManufacturing 's take Related Articles: SCM commercial-scale plant gets MHRA nod SCM offers 'blank ...

Oxford Nanopore raises $59M to scale up production of MinION sequencer

With the early access program for its MinION sequencer now in full swing, Oxford Nanopore has tapped new and existing investors for cash to fund the next stage of its evolution. And with the oversubscribed offering pulling in $59 million (£35 million), the British startup has the money to scale up ...

Validic raises $5M to fuel 'crazy' growth of data aggregation platform

their offerings as being focused on consumers, unlike Validic, which is targeting businesses. The difference ...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • next ›
  • last »